Influence of selected natural products on neutral endopeptidase activity and β-amyloid production in SK-N-SH cells

Pharmaceutical Biology

Volumn 46, Issue 6, 2008, Pages 425-432

  Ayoub, Shereen ^a   Melzig, Matthias F ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

amyloid peptide; Alzheimer's disease; Angiotensin converting enzyme; Intracellular cyclic adenosine monophosphate; Neutral endopeptidase

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; APIGENIN; CELL PROTEIN; CURCUMIN; CYCLIC AMP; DIPEPTIDYL CARBOXYPEPTIDASE; LUTEOLIN; MEMBRANE METALLOENDOPEPTIDASE; NATURAL PRODUCT; ROLIPRAM;

ARTICLE; CELL LINE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MEDICAL RESEARCH; NEUROBLASTOMA CELL; PROTEIN SECRETION; UPREGULATION;

EID: 45849132441     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.1080/13880200802055891     Document Type: Article

References (46)

1. Adlerz L, Beckman M, Holback S, Tehranian R, Cortes Toro V, Iverfeldt, K (2003): Accumulation of the amyloid precursor-like protein APLP2 and reduction of APLP1 in retinoic acid-differentiated human neuroblastoma cells upon curcumin-induced neurite retraction. Brain Res 119(1): 62-72.
2. Agnello D, Carvelli L, Muzio V, Villa P, Bottazzi B, Polentarutti N, Mennini T, Mantovani A, Ghezzi P (2000): Increased peripheral benzodiazepine binding sites and pentraxin 3 expression in the spinal cord during EAE: Relation to inflammatory cytokines and modulation by dexamethasone and rolipram J Neuroimmunol 109: 105-111.
3. Andreasen N, Blennow K (2002): Beta-Amyloid (Abeta) protein in cerebrospinal fluid as a biomarker for Alzheimer's disease. Peptides 23: 1205-1214.
4. Ayoub S, Melzig MF (2006): Induction effect of apigenin, luteolin and vinpocetin on neutral endopeptidase (NEP) and angiotensin-converting enzyme (ACE) activity of SK-N-SH cell. Nat Prod Commun (in press).
5. Chapman PF, White GL, Jones MW, Cooper-Blacketer D, Marshall VJ, Irizarry M, Younkin L, Good MA, Bliss TV, Hyman BT, Younkin SG, Hsiao KK (1999): Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat Neurosci 2: 271-276.
6. Chen Y, Zheng R, Jia Z, Ju Y (1990): Flavonoids as superoxide scavengers and antioxidant. Free Radic Biol Med 9: 19-21.
7. Chong YH, Shin YA, Suh YH (2003): Cyclic AMP inhibition of tumor necrosis factor alpha production induced by amyloidogenic C-terminal peptide of Alzheimer's amyloid precursor protein in macrophages: Involvement of multiple intracellular pathways and cyclic AMP response element binding protein. Mol Pharmacol 63: 690-698.
8. Cotman CW (1997): The β-amyloid peptide, peptide self-assembly and the emergence of biological activities. A new principle in peptide function and the induction of neuropathology. Ann N Y Acad Sci 814: 1-16.
9. Dawson TM, Ginty DD (2002): CREB family transcription factors inhibit neuronal suicide. Nature Med 8: 450-451.
10. Duarte J, Vizcaino FP, Utrilla P, Jimenez J, Tamargo J, Zarzuelo A (1993): Vasodilatory effct of flavonoids in rat aortic smooth muscle. Structure-activity relationships. General Pharmacol 24: 857-862.
11. Elsisi NS, Darling-Reed S, Lee EY, Oriaku ET, Soliman KF (2005): Ibuprofen and apigenin induce apoptosis and cell cycle arrest in activated microglia. Neurosci Lett 375: 91-96.
12. Ferrandiz ML, Alcaraz MJ (1991): Anti-inflammatory activity and inhibition of arachidonic acid metabolism by flavonoids. Agents Action 32: 283-288.
13. Ferriola PC, Cody Y, Middleton, JR (1989): Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms and structure-activity relationships. Biochem Pharmacol 38: 1617-1624.
14. Frautschy SA, Hu W, Kim P, Miller SA, Chu T, Harris-White ME, Cole GM (2001): Phenolic anti-inflammatory antioxidant reversal of Aβ-induced cognitive deficits and neuropathology. Neurobiol Aging 22: 993-1005.
15. Ganguli M, Chandra V, Kamboh MI, Johnston JM, Dodge HH, Thelma BK, Juyal RC, Pandav R, Belle SH, DeKosky ST (2000): Apolipoprotein E polymorphism and Alzheimer's disease: The Indo-US Cross-National Dementia Study. Arch Neurol 57: 824-830.
16. Giri RK, Rajagopal V, Klra VK (2004): Curcumin, the active constituent of turmeric, inhibits amyloid peptide-induced cytochemokine gene expression and CCR5-mediated chemotaxis of THP-1 monocytes by modulating early growth response-1 transcription factor. J Neurochem 91: 1199-1210.
17. Gong B, Vitolo OV, Trinchese F, Liu S, Shelanski M, Arancio O (2004): Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment. J Clin Invest 114: 1624-1634.
18. Graf K, Kunkel K, Zhang M, Grafe M, Schultz K, Schudt C, Biroc S, Fleck E, Kunkel G (1995): Activation of adenylate cyclase and phosphodiesterase inhibition enhance neutral endopeptidase activity in human endothelial cells. Peptides 16: 1273-1278.
19. Hamma E, Shiratoni K, Iwata N, Saido TC (2004): Effects of neprilysin chimeric proteins targeted to subcellular compartments on amyloid β peptide clearance in primary neurons. J Biol Chem 279: 30259-30264.
20. Haugabook SJ, Yager DM, Eckman EA, Golde TE, Younkin SG, Eckman CB (2001): High throughput screens for the identification of compounds that alter the accumulation of Alzheimer's amyloid beta peptide. J Neurosci Methods 108: 171-179.
21. Hayashi T, Sawa K, Kawasaki M, Arisawa M, Shimizu M, Morita N (1988): Inhibition of cow's milk xanthine oxidase by flavonoids. J Nat Prod 51: 345-348.
22. Hemming ML, Selkoe DJ (2005): Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor. J Biol Chem 280: 37644-37650.
23. Hooper NM (1996): The biological roles of zinc and families of zinc metalloprotease. In: Hooper BM ed. Zinc Metalloproteases in Health and Disease. London, Taylor & Francis, pp. 1-21.
24. Hu J, Igarashi A, Kamata M, Nakagawa H (2001): Angiotensin converting enzyme degrades Alzheimer amyloid-β- peptide Aβ, retards Aβ aggregation, deposit, fibril formation and inhibit cytotoxicity. J Biol Chem 276: 47863-47868.
25. Kelloff GJ, Crowell JA, Hawk ET, Steele VE, Lubet RA, Boone CW, Covey JM, Doody LA, Omenn GS, Greenwald P, Hong WK, Parkinson DR, Bagheri D, Baxter GT, Blunden M, Doeltz MK, Eisenhauer KM, Johnson K, Knapp GG, Longfellow DG, Malone WF, Nayfield SG, Seifried HE, Swall LM, Sigman CC (1996): Strategy and planning for chemopreventive drug development: Clinical development plans II. J Cell Biochem Suppl 26: 72-85.
26. Kim DS, Park SY, Kim JK (2001): Curcuminoids from Curcuma longa L (Zingiberaceae) that protect PC12 rat pheochromocytoma and normal human umbilical vein endothelial cells from beta-A (1-42) insult. Neurosci Lett 303: 57-61.
27. Ko WC, Shih CM, Lai YH, Chen JH, Huang HL (2004): Inhibitory effects of flavonoids on phosphodiesterase isoenzymes from guinea pig and their structure activity relationships. Biochem Pharmacol 68: 2087-2094.
28. Kolsch H, Jessen F, Freymann N, Kreis M, Hentschel F, Maier W, Heun R (2005): ACE I/D polymorphism is a risk factor of Alzheimer's disease but not of vascular dementia. Neurosci Lett 377: 37-39.
29. Kuppusamy UR, Das NP (1992): Effects of flavonoids on cyclic AMP phosphodiesterase and lipid mobilization in rat adipocytes. Biochem Pharmacol 44: 1307-1315.
30. Li C, Booze RM, Hersh LB (1995): Tissue-specific expression of rat neutral endopeptidase (neprilysin) mRNAs. J Biol Chem 270: 5723-5728.
31. Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM (2001): The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer's transgenic mouse. J Neurosci 21: 8370-8377.
32. Menon LG, Kuttan R, Kuttan G (1995): Inhibition of lung metastasis in mice induced by B16F10 melanoma cells by polyphenolic compounds. Cancer Lett 95: 221-225.
33. Meyer-Franke A, Kaplan MR, Pfrieger FW, Barres BA (1995): Characterization of the signaling interactions that promote the survival and growth of developing retinal ganglion cells in culture. Neuron 15: 805-819.
34. 2+ calmodulin-stimulated adenylate cyclase in rat brain. Int J Mol Med 6: 377-89.
35. Ono K, Hasegawa K, Naiki H, Yamada M (2004): Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro. J Neurosci Res 75: 742-750.
36. Paradossi-Piquard R, Petit A, Kawarai T, Sunyach C, Alves da Costa C, Vincent B, Ring S, D'Adamio L, Shen J, Muller U, St George Hyslop P, Checler F (2005): Presenilin-dependent transcriptional control of the A β-degrading enzyme neprilysin by intracellular domains of betaAPP and APLP. Neuron 46: 541-554.
37. Park SY, Kim DS (2002): Discovery of natural products from Curcuma longa that protect cells from beta-amyloid insult: A drug discovery effort against Alzheimer's disease. J Nat Prod 65: 1227-1231.
38. Patil CS, Singh VP, Satyanarayan PS, Jain NK, Singh A, Kulkarni SK (2003): Protective effect of flavonoids against aging- and lipopolysaccharide- induced cognitive impairment in mice. Pharmacology 69: 59-67.
39. Pearse DD, Pereira FC, Marcillo AE, Bates MJ, Berrocal YA, Filbin MT, Bunge MB (2004): cAMP and Schwann cells promote axonal growth and functional recovery after spinalcordinjury. Nature Med 10: 610-616.
40. Shirotani K, Tsubuki S, Iwata N, Takaki Y, Harigaya W, Maruyama K, Kiryu-Seo S, Kiyama H, Iwata H, Tomita T, Iwatsubo T, Saido TC (2001): Neprilysin degrades both amyloid beta peptides 1-40 and 1-42 most rapidly and efficiently among thiorphan- and phosphoramidon-sensitive endopeptidases. J Biol Chem 276: 21895-21901.
41. Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, Teplow DP, Ross S, Amarante P, Loeloff R, Luo Y, Fisher S, Fuller J, Edenson S, Lile J, Jarosinski MA, Biere AL, Curran E, Burgess T, Louis JC, Collins F, Treanor J, Rogers G, Citron M (1999): β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286: 725-741.
42. Vitolo OV, Sant'Angelo A, Costanzo V, Battaglia F, Arancio O, Shelanski M (2002): Amyloid beta-peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling. Proc Natl Acad Sci USA 99: 13217-13221.
43. Wang CN, Chi CW, Lin YL, Chen CF, Shiao YJ (2001): The neuroprotective effects of phytoestrogens on the amyloid beta protein-induced toxicity are mediated by abrogating the activation of caspace cascade in rat cortical neurons. J Biol Chem 276: 5287-5295.
44. Yamamoto M, Gotz ME, Ozawa H, Luckhaus C, Saito T, Rosler M, Riederer P (2000): Hippocampal level of neural specific adenylyl cyclase type I is decreased in Alzheimer's disease. Biochim Biophys Acta 1535: 60-68.
45. Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, Chen PP, Kayed R, Glabe CG, Frautschy SA, Cole GM (2005): Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 280: 5892-5901.
46. Yasojima K, Akiyama H, McGeer EG, McGeer PL (2001): Reduced neprilysin in high plaque areas of Alzheimer brain: A possible relationship to deficient degradation of beta-amyloid peptide. Neurosci Lett 297: 97-100.